Pharmacy Guide
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Pharmacy Guide
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Care Feverfew Migraine Relief Tablets
⚠ This medicine appears to have been discontinued
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Feverfew herb may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
How to take it
Care Feverfew Tablets.
Fonts Used
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you.
- Keep this leaflet. You may need to read it again.
- Ask your pharmacist if you need more information or advice.
- If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.
- You must talk to a doctor if you do not feel better or if you feel worse after 2 months.
Component
Point Sizes Used Min Max
Care Feverfew Migraine Relief Tablets Feverfew herb 100mg
Product Title
20211601
PATIENT INFORMATION LEAFLET
20211601
PCP Header Box Operator
Approved by Date
GKE
Artwork No. 901143 CRN
13876
Reason for Change
New product introduction
Suffix
C
Issued by Date MHRA/IMB submission required
Yes
9pt 9pt Helvetica LT Std
10pt 9pt Arial
60's
20211601
160 x 256mm
7
Pack Size
IG Code
Dimensions
Proof No.
Date
30.10.2017
Process Black
Point Sizes Used Min Max Colours Used
Care Feverfew Migraine Relief Tablets
Leaflet
Possible side effects
not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for 'MHRA Yellow Card' in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
MHRA Header Box
4.
Fonts Used
If you take more of this product than you should If you take more than the recommended dose, speak to a doctor, pharmacist or qualified healthcare practitioner. Take this leaflet with you. If you forget to take this product Do not take a double dose to make up for a forgotten dose. Take the next dose when it becomes due. If symptoms worsen, or persist after taking this product for 2 months, a doctor or a qualified healthcare practitioner should be consulted. If you have any questions, or are unsure about anything, please ask your doctor, pharmacist or qualified healthcare practitioner.
How to store it
CARE FEVERFEW TABLETS
Keep this medicine out of the sight and reach of children. Store in the original package. Do not use this product after the expiry date which is stated on the label or carton after EXP. The expiry date refers to the last day of that month. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Product Title
5.
POSSIBLE SIDE EFFECTS
Like all medicines, this product can cause side effects, although not everybody gets them. Common (affecting up to 1 in 20 people) side effects may include:
- Abdominal bloating.
- Indigestion.
- Heartburn.
- Digestive upsets such as wind, bloating, nausea, constipation or diarrhoea. These common side effects are often temporary, but if they persist for more than a few days, or become troublesome, stop taking the product. Uncommon (affecting fewer than 1 in 300 people) side effects:
- Mouth inflammation or mouth ulcers.
- Mild allergic skin reactions: itching and/or rash of the skin. Stop taking this product immediately if you experience any of these side effects. Other side effects: These include increased heart rate; raised blood pressure; eosinophilia; abnormal liver function tests; arthritis; renal failure and Raynauds phenomenon. If you find any of these effects troublesome, stop using the product. Speak to your doctor if you are at all concerned, if a side effect becomes serious, or you notice an effect not mentioned in this leaflet. Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any
Contents of the pack and other information
What Care Feverfew Tablets contain
- Each film-coated tablet contains 100mg of Feverfew herb (Tanacetum parthenium (L.) Schulz Bip.)
- The other ingredients are; dicalcium phosphate anhydrous; microcrystalline cellulose; silica colloidal hydrated; magnesium stearate, croscarmellose sodium; lecithin; dextrose monohydrate; sodium citrate dihydrate; dextrin. What Care Feverfew Tablets look like and contents of the pack Care Feverfew Migraine Relief Tablets are olive, film-coated round tablets. Do not use this product if you notice any discolouring or softening of the tablets, as this means they may have deteriorated. This product is available in packs of 30, 60, 90 and 120 tablets (not all sizes may be marketed). Registration number: THR 33336/0010 Traditional Herbal Registration Holder and Manufacturer: Natures Aid Ltd, St Georges Park, Preston, Lancs., PR4 2DQ, UK. Distributed by: Thornton & Ross Ltd., Huddersfield, HD7 5QH, UK. This leaflet was last revised in November 2017. For a large print, braille or audio version of this leaflet please call 01484 848164
Component
6.
Frequently asked questions about Care Feverfew Migraine Relief Tablets
How do I take Care Feverfew Migraine Relief Tablets?
Care Feverfew Migraine Relief Tablets comes as tablet. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
What is the active substance in Care Feverfew Migraine Relief Tablets?
The active substance in Care Feverfew Migraine Relief Tablets is feverfew herb.
Where does this information come from?
This leaflet reproduces the patient information leaflet approved for Care Feverfew Migraine Relief Tablets, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Can I get Care Feverfew Migraine Relief Tablets without a prescription?
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
About this leaflet
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
- Source: electronic medicines compendium (emc), Datapharm
- Active substance: feverfew herb
- Official document: view the original leaflet on emc →
⚕For healthcare professionals — Summary of Product Characteristics (SmPC)Full SmPC: dosage, interactions, contraindications, warnings+
4.1. Therapeutic indications
A traditional herbal medicinal product used for the prevention of migraine headaches based on traditional use only.
4.2. Posology and method of administration
For oral short term use only.
For adults and the elderly, take one tablet daily. Tablets should be swallowed whole with water or a little liquid. The tablets should not be chewed.
The use in children and adolescents under 18 years of age is not recommended (see section 4.4 'Special warnings and precautions for use')
Duration of use:
If symptoms worsen, or persist longer than 2 months during the use of the product, a doctor or qualified healthcare practitioner should be consulted.
4.3. Contraindications
Hypersensitivity to Feverfew, other members of the Asteraceae (Compositae) family or to any of the excipients.
4.4. Special warnings and precautions for use
Do not exceed the stated dose.
Patients who take Feverfew for migraine should have been previously diagnosed by a doctor of this condition.
If the patient experiences changes in the migraines (i.e. increase in attacks, worsening of pain, new symptoms) they should be instructed to consult their doctor.
Long-term Feverfew users who stop treatment suddenly may experience withdrawal symptoms, including rebound headaches, anxiety, difficulty sleeping, muscle stiffness, and joint pain.
Patients who are on long term therapy with Feverfew should be instructed to seek professional advice before stopping treatment.
Evidence from a limited number of in vitro studies suggests that feverfew may inhibit platelet function, the relevance of this in humans is unknown.
The use in children or adolescents under 18 years of age is not recommended due to lack of adequate data.
Each tablet contains dextrose (glucose) 0.7mg (see section 6.1); Patients with rare hereditary problems of glucose-galactose malabsorption should not take this medicine.
4.5. Interaction with other medicinal products and other forms of interaction
Drugs that affect coagulation and bleeding: Feverfew theoretically may increase the risk of bleeding when taken with drugs that affect coagulation and bleeding. Some examples include anticoagulants such as warfarin, acenocoumarol, phenindione, apixaban, edoxaban, dabigatran, rivaroxaban or parenteral anticoagulants such as dalteparin, enoxaparin and tinzaparin; or heparin, anti-platelet drugs such as clopidogrel, and non-steroidal anti-inflammatory drugs such as aspirin, ibuprofen and naproxen.
4.6. Fertility, pregnancy and lactation
Safety during pregnancy and lactation has not been established. In the absence of sufficient data, the use during pregnancy and lactation is not recommended.
Traditional experience suggests that Feverfew may stimulate menstrual flow and induce abortion.
Studies on the effects on fertility have not been carried out.
4.7. Effects on ability to drive and use machines
Studies on the ability to drive and use machines have not been performed.
4.8. Undesirable effects
The review of the adverse drug reactions reported in clinical trials indicate that most side-effects are mild and reversible.
Mouth inflammation or ulcers, including swelling of the lips, tongue irritation, bleeding of the gums, and loss of taste have been reported, usually after direct contact of the mouth with the leaves, although some people report burning after swallowing a tablet containing dried leaf.
Photosensitivity (sensitivity to sunlight or sunlamps) has been reported with other herbs in the Asteraceae (Compositae) plant family.
Indigestion, nausea, flatulence, constipation, diarrhoea, abdominal bloating, and heartburn have been reported rarely.
Feverfew can also cause allergic rashes.
Increased heart rate in some patients has been reported in one small study. Other side effects that have been reported spontaneously are eosinophilia, abnormal liver function tests, arthritis, renal failure, Raynaud's phenomenon and hypertension.
These were spontaneously generated adverse drug reactions during post-marketing surveillance and the causal relation to Feverfew cannot be established.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continual monitoring of the benefit/risk of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow card Scheme at www.mhra.gov.uk/yellowcard or search for 'MHRA Yellow Card' in the Google Play or Apple App Store.
4.9. Overdose
There are well documented cases of overdose with Feverfew.
In cases of overdose the treatment should be supportive. Since there is a theoretical increased risk of bleeding, patients should be closely monitored for signs of bleeding.
💬 Ask about this leaflet
Ask anything about Care Feverfew Migraine Relief Tablets. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.